Drugplain

XTAMPZA ER 13.5 mg/1

OXYCODONE · CAPSULE, EXTENDED RELEASE · Collegium Pharmaceutical, Inc.

No Recall HistoryCurrently in Shortage
Plain English

Xtampza ER is an extended-release oxycodone capsule taken by mouth to treat moderate to severe pain. As an opioid medication, it works by changing how your body feels and responds to pain.

Key Facts

Brand Name
XTAMPZA ER
Generic Name
OXYCODONE
NDC Code (Product)
24510-115
Manufacturer
Collegium Pharmaceutical, Inc.
Strength
13.5 mg/1
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Marketing Status
DEA Schedule
Schedule II (Controlled)
Application #
NDA208090
Drug Class
Opioid Agonist [EPC]
Marketing Start
05/10/2016

Recall History

No Recall History

Frequently Asked Questions

What is XTAMPZA ER used for?

Xtampza ER is an extended-release oxycodone capsule taken by mouth to treat moderate to severe pain. As an opioid medication, it works by changing how your body feels and responds to pain.

Is XTAMPZA ER a controlled substance?

Yes, XTAMPZA ER is classified as CII under the DEA Controlled Substances Act.

What is the generic name for XTAMPZA ER?

The generic name for XTAMPZA ER is OXYCODONE. There are 12 other brand versions of OXYCODONE.

What is the NDC code for XTAMPZA ER 13.5 mg/1?

The NDC (National Drug Code) for XTAMPZA ER 13.5 mg/1 is 24510-115, listed by Collegium Pharmaceutical, Inc..